It has been a very busy spring for PharmaSafe and we are happy to announce that we have three freshly-minted PhDs!
Elin Thuy Phuong Ngo successfully defended her thesis on April 26, 2023.
Thesis title:
Trial lecture title:
Interprofessional collaboration in pregnancy care for safe use of medication
Supervisors:
Prof. Hedvig Nordeng, University of Oslo, Oslo, Norway
Prof. David Wright, University of East Anglia, Norwich, United Kingdom
Committe:
1st Opponent: Prof. Katja Taxis, University of Groningen, Groningen, The Netherlands
2nd Opponent: Dr. Hege Sletvold, NORD Universitet, Bodø, Norway
3rd Opponent: Prof. Arild Rustan, University of Oslo, Oslo, Norway
Emilie Willoch Olstad successfully defended her thesis on May 12, 2023.
Title:
Prenatal Medication Exposure, DNA Methylation and Child Neurodevelopment
Trial Lecture:
Importance of pharmacoepigenetics and pharmacogenetics for improving diagnosis and treatment of neuropsychiatric disorders
Supervisors:
Prof. Hedvig Nordeng, University of Oslo, Oslo, Norway
Dr. Kristina Gervin, Oslo University Hospital, Oslo, Norway
Committee:
1st Opponent: Ass. Prof. Esther Walton, University of Bath, Bath, United Kingdom
2nd Opponent: Dr. Astanand Jugessur, Norwegian Institute of Public Health, Oslo, Norway
3rd Opponent: Dr. Espen Molden, University of Oslo, Oslo, Norway
Lene Maria Sundbakk successfully defended her thesis on June 2, 2023.
Title:
Trial Lecture:
Nonadherence to and discontinuation of chronic psychotropic medications in pregnancy: prevalence and implications for mother and infants
Supervisors:
Prof. Hedvig Nordeng, University of Oslo, Oslo, Norway
Ass. Prof. Mollie Wood, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Committee:
1st Opponent: Dr. Sascha Dublin, Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA
2nd Opponent: Dr. Michael Due Larsen, Norwegian University of Science and Technology, Trondheim, Norway
3rd Opponent: Dr. Osman Gani, University of Oslo, Oslo, Norway